Clinical Cancer Research Bridging the Lab and the Clinic in Cancer Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inoue, K.
Right arrow Articles by Shuin, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inoue, K.
Right arrow Articles by Shuin, T.
Clinical Cancer Research Vol. 8, 1863-1870, June 2002
© 2002 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

The Prognostic Value of Angiogenesis and Metastasis-related Genes for Progression of Transitional Cell Carcinoma of the Renal Pelvis and Ureter

Keiji Inoue1,2, Masayuki Kamada1, Joel W. Slaton, Satoshi Fukata, Chiaki Yoshikawa, Pheroze Tamboli, Colin P. N. Dinney and Taro Shuin

Department of Urology, Kochi Medical School, Nankoku, Kochi, 783-8505 Japan [K. I., M. K., S. F., C. Y., T. S.], and Departments of Cancer Biology [J. W. S., C. P. N. D.] and Pathology [P. T.], The University of Texas M. D. Cancer Center, Houston, Texas 77030

Purpose: We reported previously that angiogenesis evaluated by intratumor microvessel density (MVD), expression of such angiogenic factors as vascular endothelial cell growth factor (VEGF) and basic fibroblast growth factor (bFGF), and the matrix metalloproteinase-9:E-cadherin ratio (M:E ratio) could identify patients with advanced transitional cell carcinoma (TCC) of the bladder for whom chemotherapy and cystectomy will be unsuccessful. In the present study, we evaluated the significance of the M:E ratio as a predictor for prognosis for patients with TCC in the upper urinary tract (TCC-UUT).

Experimental Design: We evaluated MVD by immunohistochemistry and the expression of angiogenic and metastasis-related factors by in situ hybridization in 55 nephroureterectomy specimens from patients who received no neoadjuvant therapy. The expression of angiogenesis, angiogenic and metastasis-related factors, and clinicopathological characteristics were evaluated for their correlation with metastasis, recurrence, and disease prognosis.

Results: We found that tumor grade and pathological stage were important predictors for metastasis and survival in these patients. The expression level of matrix metalloproteinase type 9 (MMP-9) and type 2 (MMP-2) and the M:E ratio correlated with MVD. Increased MVD, elevated expression levels of MMP-9 and MMP-2, and a higher M:E ratio were associated with poor prognosis. Moreover, lower expression levels of E-cadherin were associated with fewer recurrences in the urinary bladder. Multivariate analysis indicated that the M:E ratio and E-cadherin expression were independent prognostic factors for disease progression and intravesical recurrence, respectively.

Conclusion: We suggest that the M:E ratio and E-cadherin expression may be targets for novel therapeutic strategies.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
P. C. Black, G. A. Brown, T. Inamoto, M. Shrader, A. Arora, A. O. Siefker-Radtke, L. Adam, D. Theodorescu, X. Wu, M. F. Munsell, et al.
Sensitivity to Epidermal Growth Factor Receptor Inhibitor Requires E-Cadherin Expression in Urothelial Carcinoma Cells
Clin. Cancer Res., March 1, 2008; 14(5): 1478 - 1486.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. R. McClelland, S. L. Carskadon, L. Zhao, E. S. White, D. G. Beer, M. B. Orringer, A. Pickens, A. C. Chang, and D. A. Arenberg
Diversity of the Angiogenic Phenotype in Non-Small Cell Lung Cancer
Am. J. Respir. Cell Mol. Biol., March 1, 2007; 36(3): 343 - 350.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
H. J. Kim, J. W. Lim, D. H. Lee, Y. T. Ko, J. H. Oh, and Y. W. Kim
Transitional Cell Carcinoma Involving the Distal Ureter: Assessment With Transrectal and Color Doppler Ultrasonography
J. Ultrasound Med., December 1, 2005; 24(12): 1625 - 1633.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Nakanishi, S. Hiroi, S. Tominaga, S. Aida, H. Kasamatsu, S. Matsuyama, T. Matsuyama, and T. Kawai
Expression of Hypoxia-Inducible Factor-1{alpha} Protein Predicts Survival in Patients with Transitional Cell Carcinoma of the Upper Urinary Tract
Clin. Cancer Res., April 1, 2005; 11(7): 2583 - 2590.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. W. Fisher, A. Jain, M. Tayback, and N. S. Fedarko
Small Integrin Binding Ligand N-Linked Glycoprotein Gene Family Expression in Different Cancers
Clin. Cancer Res., December 15, 2004; 10(24): 8501 - 8511.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Kumar, Z.-R. Liu, L. Thapa, and R.-Y. Qin
Anti-angiogenic effects of somatostatin receptor subtype 2 on human pancreatic cancer xenografts
Carcinogenesis, November 1, 2004; 25(11): 2075 - 2081.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Sanceau, S. Truchet, and B. Bauvois
Matrix Metalloproteinase-9 Silencing by RNA Interference Triggers the Migratory-adhesive Switch in Ewing's Sarcoma Cells
J. Biol. Chem., September 19, 2003; 278(38): 36537 - 36546.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.